199 related articles for article (PubMed ID: 19036883)
1. Type 2 deiodinase expression is induced by peroxisomal proliferator-activated receptor-gamma agonists in skeletal myocytes.
Grozovsky R; Ribich S; Rosene ML; Mulcahey MA; Huang SA; Patti ME; Bianco AC; Kim BW
Endocrinology; 2009 Apr; 150(4):1976-83. PubMed ID: 19036883
[TBL] [Abstract][Full Text] [Related]
2. Thyroid hormone activation by type 2 deiodinase mediates exercise-induced peroxisome proliferator-activated receptor-γ coactivator-1α expression in skeletal muscle.
Bocco BM; Louzada RA; Silvestre DH; Santos MC; Anne-Palmer E; Rangel IF; Abdalla S; Ferreira AC; Ribeiro MO; Gereben B; Carvalho DP; Bianco AC; Werneck-de-Castro JP
J Physiol; 2016 Sep; 594(18):5255-69. PubMed ID: 27302464
[TBL] [Abstract][Full Text] [Related]
3. Thyroid Hormone Signaling in Male Mouse Skeletal Muscle Is Largely Independent of D2 in Myocytes.
Werneck-de-Castro JP; Fonseca TL; Ignacio DL; Fernandes GW; Andrade-Feraud CM; Lartey LJ; Ribeiro MB; Ribeiro MO; Gereben B; Bianco AC
Endocrinology; 2015 Oct; 156(10):3842-52. PubMed ID: 26214036
[TBL] [Abstract][Full Text] [Related]
4. A Global Loss of Dio2 Leads to Unexpected Changes in Function and Fiber Types of Slow Skeletal Muscle in Male Mice.
Carmody C; Ogawa-Wong AN; Martin C; Luongo C; Zuidwijk M; Sager B; Petersen T; Roginski Guetter A; Janssen R; Wu EY; Bogaards S; Neumann NM; Hau K; Marsili A; Boelen A; Silva JE; Dentice M; Salvatore D; Wagers AJ; Larsen PR; Simonides WS; Zavacki AM
Endocrinology; 2019 May; 160(5):1205-1222. PubMed ID: 30951174
[TBL] [Abstract][Full Text] [Related]
5. The PPAR gamma agonist troglitazone induces musclin mRNA expression in human myotubes.
Staiger H; Haas C; Machicao F; Häring HU
Horm Metab Res; 2006 Sep; 38(9):614-6. PubMed ID: 16981146
[No Abstract] [Full Text] [Related]
6. Palmitate-induced down-regulation of sortilin and impaired GLUT4 trafficking in C2C12 myotubes.
Tsuchiya Y; Hatakeyama H; Emoto N; Wagatsuma F; Matsushita S; Kanzaki M
J Biol Chem; 2010 Nov; 285(45):34371-81. PubMed ID: 20805226
[TBL] [Abstract][Full Text] [Related]
7. Type II iodothyronine deiodinase provides intracellular 3,5,3'-triiodothyronine to normal and regenerating mouse skeletal muscle.
Marsili A; Tang D; Harney JW; Singh P; Zavacki AM; Dentice M; Salvatore D; Larsen PR
Am J Physiol Endocrinol Metab; 2011 Nov; 301(5):E818-24. PubMed ID: 21771965
[TBL] [Abstract][Full Text] [Related]
8. Mice with a targeted deletion of the type 2 deiodinase are insulin resistant and susceptible to diet induced obesity.
Marsili A; Aguayo-Mazzucato C; Chen T; Kumar A; Chung M; Lunsford EP; Harney JW; Van-Tran T; Gianetti E; Ramadan W; Chou C; Bonner-Weir S; Larsen PR; Silva JE; Zavacki AM
PLoS One; 2011; 6(6):e20832. PubMed ID: 21698184
[TBL] [Abstract][Full Text] [Related]
9. Early Developmental Disruption of Type 2 Deiodinase Pathway in Mouse Skeletal Muscle Does Not Impair Muscle Function.
Ignacio DL; Silvestre DH; Anne-Palmer E; Bocco BM; Fonseca TL; Ribeiro MO; Gereben B; Bianco AC; Werneck-de-Castro JP
Thyroid; 2017 Apr; 27(4):577-586. PubMed ID: 27967605
[TBL] [Abstract][Full Text] [Related]
10. A Type 2 Deiodinase-Dependent Increase in
An X; Ogawa-Wong A; Carmody C; Ambrosio R; Cicatiello AG; Luongo C; Salvatore D; Handy DE; Larsen PR; Wajner SM; Dentice M; Zavacki AM
Thyroid; 2021 Jan; 31(1):115-127. PubMed ID: 32787533
[No Abstract] [Full Text] [Related]
11. Stearoyl-coenzyme A desaturase 1 gene expression increases after pioglitazone treatment and is associated with peroxisomal proliferator-activated receptor-gamma responsiveness.
Yao-Borengasser A; Rassouli N; Varma V; Bodles AM; Rasouli N; Unal R; Phanavanh B; Ranganathan G; McGehee RE; Kern PA
J Clin Endocrinol Metab; 2008 Nov; 93(11):4431-9. PubMed ID: 18697866
[TBL] [Abstract][Full Text] [Related]
12. Absence of thyroid hormone activation during development underlies a permanent defect in adaptive thermogenesis.
Hall JA; Ribich S; Christoffolete MA; Simovic G; Correa-Medina M; Patti ME; Bianco AC
Endocrinology; 2010 Sep; 151(9):4573-82. PubMed ID: 20660060
[TBL] [Abstract][Full Text] [Related]
13. Thyroid hormone homeostasis and action in the type 2 deiodinase-deficient rodent brain during development.
Galton VA; Wood ET; St Germain EA; Withrow CA; Aldrich G; St Germain GM; Clark AS; St Germain DL
Endocrinology; 2007 Jul; 148(7):3080-8. PubMed ID: 17332058
[TBL] [Abstract][Full Text] [Related]
14. Type 2 iodothyronine deiodinase levels are higher in slow-twitch than fast-twitch mouse skeletal muscle and are increased in hypothyroidism.
Marsili A; Ramadan W; Harney JW; Mulcahey M; Castroneves LA; Goemann IM; Wajner SM; Huang SA; Zavacki AM; Maia AL; Dentice M; Salvatore D; Silva JE; Larsen PR
Endocrinology; 2010 Dec; 151(12):5952-60. PubMed ID: 20881246
[TBL] [Abstract][Full Text] [Related]
15. Comparison of vascular relaxation, lipolysis and glucose uptake by peroxisome proliferator-activated receptor-gamma activation in +db/+m and +db/+db mice.
Seto SW; Lam TY; Leung GP; Au AL; Ngai SM; Chan SW; Kwan YW
Eur J Pharmacol; 2007 Oct; 572(1):40-8. PubMed ID: 17603034
[TBL] [Abstract][Full Text] [Related]
16. Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4.
Schneider MJ; Fiering SN; Pallud SE; Parlow AF; St Germain DL; Galton VA
Mol Endocrinol; 2001 Dec; 15(12):2137-48. PubMed ID: 11731615
[TBL] [Abstract][Full Text] [Related]
17. Tissue-specific inactivation of type 2 deiodinase reveals multilevel control of fatty acid oxidation by thyroid hormone in the mouse.
Fonseca TL; Werneck-De-Castro JP; Castillo M; Bocco BM; Fernandes GW; McAninch EA; Ignacio DL; Moises CC; Ferreira AR; Gereben B; Bianco AC
Diabetes; 2014 May; 63(5):1594-604. PubMed ID: 24487027
[TBL] [Abstract][Full Text] [Related]
18. PPAR-gamma agonists induce the expression of VEGF and its receptors in cultured cardiac myofibroblasts.
Chintalgattu V; Harris GS; Akula SM; Katwa LC
Cardiovasc Res; 2007 Apr; 74(1):140-50. PubMed ID: 17320065
[TBL] [Abstract][Full Text] [Related]
19. Role of type 2 deiodinase in response to acute lung injury (ALI) in mice.
Barca-Mayo O; Liao XH; DiCosmo C; Dumitrescu A; Moreno-Vinasco L; Wade MS; Sammani S; Mirzapoiazova T; Garcia JG; Refetoff S; Weiss RE
Proc Natl Acad Sci U S A; 2011 Dec; 108(49):E1321-9. PubMed ID: 22065740
[TBL] [Abstract][Full Text] [Related]
20. Type-2 iodothyronine 5'deiodinase (D2) in skeletal muscle of C57Bl/6 mice. II. Evidence for a role of D2 in the hypermetabolism of thyroid hormone receptor alpha-deficient mice.
Ramadan W; Marsili A; Larsen PR; Zavacki AM; Silva JE
Endocrinology; 2011 Aug; 152(8):3093-102. PubMed ID: 21652727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
